BioSyent Statistics
Total Valuation
BioSyent has a market cap or net worth of CAD 123.33 million. The enterprise value is 108.43 million.
Market Cap | 123.33M |
Enterprise Value | 108.43M |
Important Dates
The next estimated earnings date is Friday, May 23, 2025.
Earnings Date | May 23, 2025 |
Ex-Dividend Date | Feb 28, 2025 |
Share Statistics
BioSyent has 11.26 million shares outstanding. The number of shares has decreased by -2.98% in one year.
Current Share Class | n/a |
Shares Outstanding | 11.26M |
Shares Change (YoY) | -2.98% |
Shares Change (QoQ) | -0.90% |
Owned by Insiders (%) | 14.14% |
Owned by Institutions (%) | 19.21% |
Float | 8.58M |
Valuation Ratios
The trailing PE ratio is 17.78 and the forward PE ratio is 13.52.
PE Ratio | 17.78 |
Forward PE | 13.52 |
PS Ratio | 3.52 |
PB Ratio | 3.52 |
P/TBV Ratio | 4.09 |
P/FCF Ratio | 14.29 |
P/OCF Ratio | 14.24 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.14, with an EV/FCF ratio of 12.56.
EV / Earnings | 14.91 |
EV / Sales | 3.10 |
EV / EBITDA | 11.14 |
EV / EBIT | 11.81 |
EV / FCF | 12.56 |
Financial Position
The company has a current ratio of 4.53, with a Debt / Equity ratio of 0.03.
Current Ratio | 4.53 |
Quick Ratio | 3.49 |
Debt / Equity | 0.03 |
Debt / EBITDA | 0.11 |
Debt / FCF | 0.12 |
Interest Coverage | 155.25 |
Financial Efficiency
Return on equity (ROE) is 20.84% and return on invested capital (ROIC) is 15.94%.
Return on Equity (ROE) | 20.84% |
Return on Assets (ROA) | 13.85% |
Return on Invested Capital (ROIC) | 15.94% |
Return on Capital Employed (ROCE) | 25.54% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.85 |
Inventory Turnover | 1.28 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.01% in the last 52 weeks. The beta is 0.45, so BioSyent's price volatility has been lower than the market average.
Beta (5Y) | 0.45 |
52-Week Price Change | +26.01% |
50-Day Moving Average | 10.81 |
200-Day Moving Average | 10.89 |
Relative Strength Index (RSI) | 55.79 |
Average Volume (20 Days) | 5,270 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioSyent had revenue of CAD 35.03 million and earned 7.27 million in profits. Earnings per share was 0.62.
Revenue | 35.03M |
Gross Profit | 27.86M |
Operating Income | 9.18M |
Pretax Income | 9.78M |
Net Income | 7.27M |
EBITDA | 9.60M |
EBIT | 9.18M |
Earnings Per Share (EPS) | 0.62 |
Balance Sheet
The company has 15.94 million in cash and 1.04 million in debt, giving a net cash position of 14.90 million or 1.32 per share.
Cash & Cash Equivalents | 15.94M |
Total Debt | 1.04M |
Net Cash | 14.90M |
Net Cash Per Share | 1.32 |
Equity (Book Value) | 35.00M |
Book Value Per Share | 3.10 |
Working Capital | 19.07M |
Cash Flow
In the last 12 months, operating cash flow was 8.66 million and capital expenditures -32,657, giving a free cash flow of 8.63 million.
Operating Cash Flow | 8.66M |
Capital Expenditures | -32,657 |
Free Cash Flow | 8.63M |
FCF Per Share | 0.77 |
Margins
Gross margin is 79.52%, with operating and profit margins of 26.21% and 20.75%.
Gross Margin | 79.52% |
Operating Margin | 26.21% |
Pretax Margin | 27.93% |
Profit Margin | 20.75% |
EBITDA Margin | 27.41% |
EBIT Margin | 26.21% |
FCF Margin | 24.64% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.83%.
Dividend Per Share | 0.20 |
Dividend Yield | 1.83% |
Dividend Growth (YoY) | 12.12% |
Years of Dividend Growth | 3 |
Payout Ratio | 28.61% |
Buyback Yield | 2.98% |
Shareholder Yield | 4.81% |
Earnings Yield | 5.89% |
FCF Yield | 7.00% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BioSyent has an Altman Z-Score of 13.8.
Altman Z-Score | 13.8 |
Piotroski F-Score | n/a |